Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015 (2015), Article ID 608216, 10 pages
http://dx.doi.org/10.1155/2015/608216
Clinical Study

Effects of Oral L-Carnitine on Liver Functions after Transarterial Chemoembolization in Intermediate-Stage HCC Patients

1Second Department of Internal Medicine, Osaka Medical College, 2-7 Daigakumachi, Takatsuki, Osaka 569-8686, Japan
2Department of Internal Medicine, Sohag Faculty of Medicine, Sohag University, Sohag 82524, Egypt

Received 26 May 2015; Revised 7 September 2015; Accepted 15 October 2015

Academic Editor: Ekihiro Seki

Copyright © 2015 Abeer Hassan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. X. Bosch, J. Ribes, R. Cléries, and M. Díaz, “Epidemiology of hepatocellular carcinoma,” Clinics in Liver Disease, vol. 9, no. 2, pp. 191–211, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Sangiovanni, G. M. Prati, P. Fasani et al., “The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients,” Hepatology, vol. 43, no. 6, pp. 1303–1310, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Forner, M. E. Reig, C. R. De Lope, and J. Bruix, “Current strategy for staging and treatment: the BCLC update and future prospects,” Seminars in Liver Disease, vol. 30, no. 1, pp. 61–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. W. Min, J. Kim, S. Kim et al., “Risk factors and a predictive model for acute hepatic failure after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma,” Liver International, vol. 33, no. 2, pp. 197–202, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. I.-F. Hsin, C.-Y. Hsu, H.-C. Huang et al., “Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction,” Journal of Clinical Gastroenterology, vol. 45, no. 6, pp. 556–562, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Takayasu, “Transarterial chemoembolization for hepatocellular carcinoma over three decades: current progress and perspective,” Japanese Journal of Clinical Oncology, vol. 42, no. 4, pp. 247–255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. B. S. Kendler, “Carnitine: an overview of its role in preventive medicine,” Preventive Medicine, vol. 15, no. 4, pp. 373–390, 1986. View at Publisher · View at Google Scholar · View at Scopus
  8. C. J. Rebouche, “Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism,” Annals of the New York Academy of Sciences, vol. 1033, pp. 30–41, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. C. Cave, R. T. Hurt, T. H. Frazier et al., “Obesity, inflammation, and the potential application of pharmaconutrition,” Nutrition in Clinical Practice, vol. 23, no. 1, pp. 16–34, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Hatamkhani, H. Khalili, I. Karimzadeh, S. Dashti-Khavidaki, A. Abdollahi, and S. Jafari, “Carnitine for prevention of antituberculosis drug-induced hepatotoxicity: a randomized, clinical trial,” Journal of Gastroenterology and Hepatology, vol. 29, no. 5, pp. 997–1004, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Dobrzyńska, B. Szachowicz-Petelska, E. Skrzydlewska, and Z. Figaszewski, “Effect of L-carnitine on liver cell membranes in ethanol-intoxicated rats,” Chemico-Biological Interactions, vol. 188, no. 1, pp. 44–51, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. S. Hashemi, A. Souzani, M. Meshkani et al., “Efficacy of L-carnitine on liver function in childrens under chemotherapy with acute lymphoblastic leukemia,” Iranian Journal of Pediatric Hematology Oncology, vol. 1, no. 2, pp. 43–47, 2012. View at Google Scholar
  13. M. Malaguarnera, M. P. Gargante, C. Russo et al., “L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis—a randomized and controlled clinical trial,” The American Journal of Gastroenterology, vol. 105, no. 6, pp. 1338–1345, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Malaguarnera, R. Bella, M. Vacante et al., “Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy,” Scandinavian Journal of Gastroenterology, vol. 46, no. 6, pp. 750–759, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Malaguarnera, M. Vacante, M. Giordano et al., “L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin,” World Journal of Gastroenterology, vol. 17, no. 39, pp. 4414–4420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Nishikawa and Y. Osaki, “Clinical significance of therapy using branched-chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma,” Hepatology Research, vol. 44, no. 2, pp. 149–158, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Kudo, N. Izumi, N. Kokudo et al., “Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the japan society of hepatology (JSH) 2010 updated version,” Digestive Diseases, vol. 29, no. 3, pp. 339–364, 2011. View at Publisher · View at Google Scholar
  18. Y.-S. Huang, J.-H. Chiang, J.-C. Wu, F.-Y. Chang, and S.-D. Lee, “Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test,” The American Journal of Gastroenterology, vol. 97, no. 5, pp. 1223–1227, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Campos, R. Huertas, G. Lorenzo et al., “Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy,” Muscle and Nerve, vol. 16, no. 2, pp. 150–153, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Muto, S. Sato, A. Watanabe et al., “Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis,” Clinical Gastroenterology and Hepatology, vol. 3, no. 7, pp. 705–713, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Ishigami, K. Hayashi, Y. Katano, A. Itoh, Y. Hirooka, and H. Goto, “Impact of early elevation of serum bilirubin during treatment with pegylated interferon and ribavirin in patients with chronic hepatitis C,” Hepatology Research, vol. 40, no. 10, pp. 963–970, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J.-L. Li, Q.-Y. Wang, H.-Y. Luan, Z.-C. Kang, and C.-B. Wang, “Effects of L-carnitine against oxidative stress in human hepatocytes: involvement of peroxisome proliferator-activated receptor alpha,” Journal of Biomedical Science, vol. 19, no. 1, article 32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Cayir, A. Karadeniz, A. Yildirim et al., “Protective effect of L-carnitine against cisplatin-induced liver and kidney oxidant injury in rats,” Central European Journal of Medicine, vol. 4, no. 2, pp. 184–191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Koreeda, T. Seki, K. Okazaki, S. K. Ha-Kawa, and S. Sawada, “Effects of late evening snack including branched-chain amino acid on the function of hepatic parenchymal cells in patients with liver cirrhosis,” Hepatology Research, vol. 41, no. 5, pp. 417–422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Nishikawa, Y. Osaki, T. Inuzuka et al., “Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 18, no. 12, pp. 1379–1384, 2012. View at Publisher · View at Google Scholar · View at Scopus